Kati Maharry

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Guido Marcucci, Kati Maharry, Yue-Zhong Wu et al. · Journal of Clinical Oncology · 2010 · 764 citations · Full text

Medicine, Hematology, Oncology +17

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated <i>BRAF</i> V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

Josep Tabernero, Axel Grothey, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2021 · 544 citations · Full text

Medicine, Oncology, Pharmacology +16

A Computerized Reminder System to Increase the Use of Preventive Care for Hospitalized Patients

Paul Dexter, Susan M. Perkins, J. Marc Overhage et al. · New England Journal of Medicine · 2001 · 531 citations

Medicine, Health Informatics, Preventive Medicine +17

Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics

Gi-Bang Koo, Da‐Gyum Lee, Woo-Jung Kim et al. · Cell Research · 2015 · 500 citations · Full text

Medicine, Cancer Biology, Oncology +16